Trends Pharmacol Sci. 2011 May;32(5):281-9. Epub 2011 Jan 20.

Treatment of nicotine addiction: present therapeutic options and pipeline developments.

Source

Centro per la Prevenzione e Cura del Tabagismo (CPCT), Azienda Ospedaliero-Universitaria 'Policlinico-Vittorio Emanuele', Università di Catania, Catania, Italy. polosa@unict.it

Abstract

Tobacco use is a global pandemic that poses a substantial and costly health burden. There are some treatment options are available, but currently marketed smoking-cessation drugs lack high levels of efficacy, particularly in real-life settings. Consequently, there is a compelling need for more effective pharmacotherapies to aid smokers in maintaining long-term abstinence. Advances in the understanding of the mechanisms involved in nicotine dependence have recently been translated into new medications and vaccines that interfere with nicotine signaling, many of which are currently at an advanced stage of development. In the present article we review current and emerging pharmacotherapies for tobacco dependence, focusing on the mechanistic rationale for their potential anti-addiction efficacy, major findings in preclinical and clinical studies, and future research directions.

PMID:: 21256603; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

R01 DA002277-33/DA/NIDA NIH HHS/United States

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Review Nicotine vaccines to assist with smoking cessation: current status of research. [Drugs. 2012]
Review Nicotine vaccines to assist with smoking cessation: current status of research.
Raupach T, Hoogsteder PH, Onno van Schayck CP. Drugs. 2012 Mar 5; 72(4):e1-16.
[Current and future medical drugs for smoking cessation]. [Laryngorhinootologie. 2009]
[Current and future medical drugs for smoking cessation].
Kusma B, Mache S, Deissenrieder F, Quarcoo D, Welte T, Groneberg D. Laryngorhinootologie. 2009 Jun; 88(6):410-9; quiz 420-2. Epub 2009 Jun 5.
Review Adverse effects and tolerability of medications for the treatment of tobacco use and dependence. [Drugs. 2010]
Review Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.
Hays JT, Ebbert JO. Drugs. 2010 Dec 24; 70(18):2357-72.
Review Mechanism-based medication development for the treatment of nicotine dependence. [Acta Pharmacol Sin. 2009]
Review Mechanism-based medication development for the treatment of nicotine dependence.
Xi ZX, Spiller K, Gardner EL. Acta Pharmacol Sin. 2009 Jun; 30(6):723-39. Epub 2009 May 11.
Review Emerging pharmacotherapies for smoking cessation. [Am J Health Syst Pharm. 2007]
Review Emerging pharmacotherapies for smoking cessation.
Garwood CL, Potts LA. Am J Health Syst Pharm. 2007 Aug 15; 64(16):1693-8.

See reviews... See all...

Cited by 3 PubMed Central articles

Neurophysiology of Nicotine Addiction. [J Addict Res Ther. 2011]
Neurophysiology of Nicotine Addiction.
Dani JA, Jenson D, Broussard JI, De Biasi M. J Addict Res Ther. 2011 Apr 20; S1(1).
Anti-addiction vaccines. [F1000 Med Rep. 2011]
Anti-addiction vaccines.
Shen X, Orson FM, Kosten TR. F1000 Med Rep. 2011; 3:20. Epub 2011 Oct 3.
Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. [BMC Public Health. 2011]
Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study.
Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C. BMC Public Health. 2011 Oct 11; 11:786. Epub 2011 Oct 11.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Treatment of nicotine addiction: present therapeutic options and pipeline develo...
Treatment of nicotine addiction: present therapeutic options and pipeline developments.
Trends Pharmacol Sci. 2011 May ;32(5):281-9. Epub 2011 Jan 20 .

PubMed
Door-to-door canvassing for immunization program acceleration in Mozambique: ach...
Door-to-door canvassing for immunization program acceleration in Mozambique: achievements and costs.
Int J Health Serv. 1990 ;20(4):717-25.

PubMed
Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a ...
Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smoking.
BMC Public Health. 2011 Jan 19 ;11:44.

PubMed
Brain magnetic resonance imaging with contrast dependent on blood oxygenation.
Brain magnetic resonance imaging with contrast dependent on blood oxygenation.
Proc Natl Acad Sci U S A. 1990 Dec ;87(24):9868-72.

PubMed
[Effect of Tuina on oxygen free radicals metabolism in patients with chronic fat...
[Effect of Tuina on oxygen free radicals metabolism in patients with chronic fatigue syndrome].
Zhongguo Zhen Jiu. 2010 Nov ;30(11):946-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: